Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes

By Levin Philip   Wei Wenhui   Wang Li   Pan Chunshen   Douglas Damon   Baser Onur  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite

Therapeutically interchangeable? A study of real‐world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 3, 2015-03 ,pp. : 245-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Real‐World Study of the Effect of Timing of Insulin Initiation on Outcomes in Older Medicare Beneficiaries with Type 2 Diabetes Mellitus

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 5, 2015-05 ,pp. : 893-901

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin

By McAdam-Marx Carrie   Yu Junhua   Bouchard Jonathan   Aagren Mark   Brixner Diana I.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 191-201

Informa Healthcare

Access to resources Recommend Favorite

Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*

By Jones Stephen   Benroubi Marian   Castell Conxa   Goday Albert   Liebl Andreas   Timlin Louise   Nicolay Claudia   Simpson Alexander   Tynan Aodan  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 691-700

Informa Healthcare

Access to resources Recommend Favorite